Headquartered in Bedford, Massachusetts, Anika Therapeutics, Inc. is a global, integrated joint preservation and regenerative therapies company. Anika is committed to delivering therapies to improve the lives of patients across a continuum of care from osteoarthritis pain management to joint preservation and restoration.
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Anika Therapeutics news
06.05.2022
Anika Therapeutics' GAAP loss for 3 months of 2022 was $2.933 million, compared to a profit of $2.838 million in the previous year. Revenue increased by 7% to $36.693 million against $34.292 million a year earlier.
Source: ir.anika.com
09.03.2022
Anika Therapeutics' GAAP net income for 2021 was $4.134 million, compared to a loss of $23.982 million in the previous year. Revenue increased by 13.3% to $147.794 million from $130.457 million a year earlier.
Source: 
ir.anikatherapeutics.com
ir.anikatherapeutics.com
05.11.2021
Anika Therapeutics reported a GAAP net profit of $9.927 million for 9M 2021, compared to a loss of $8.326 million in the previous year. Revenue increased by 14.5% to $111.973 million from $97.769 million a year earlier.
Source: ir.anikatherapeutics.com
ir.anikatherapeutics.com
06.08.2021
Anika Therapeutics reported a GAAP net profit of $9.369 million for 6 months of 2021, compared to a loss of $1.915 million in the previous year. Revenue increased 9.6% to $72.437 million from $66.075 million a year earlier.
Source: ir.anikatherapeutics.com
ir.anikatherapeutics.com
General information
| Company name | Anika Therapeutics |
|---|---|
| Tags | #pharmacy |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
| Business address | 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000 |
| Mailing address | 32 WIGGINS AVENUE BEDFORD MA 01730 |
| Website | www.anikatherapeutics.com |
| Information disclosure | www.sec.gov |
English (US) 